作者: Raiiv Nayar , Mark C. Manning
DOI:
关键词:
摘要: Outsourcing is often considered a way to expedite drug development, but other options exist for companies that don't choose it - or run up against the capacity shortage. The resources devoted speeding discovery process led combinatorial libraries, high-throughput screening, proteomics, and genomics. Now same types of innovation can be applied development prevent valuable lead compounds from sitting idle on shelf.